Decoding the complexity of Alzheimer's disease
Alzheimer's disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.
Sep 28, 2023
0
22
Alzheimer's disease affects more than 6 million people in the United States, and there are very few FDA-approved treatments that can slow the progression of the disease.
Sep 28, 2023
0
22
Long COVID patients have clear differences in immune and hormone function to patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
Sep 25, 2023
0
80
Working consistently in an occupation with medium or high occupational physical activity was linked to an increased risk of cognitive impairment, according to a new study by the Norwegian National Centre of Ageing and Health ...
Sep 14, 2023
1
39
A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...
Aug 31, 2023
0
31
Nearly half of all patients with brain metastasis experience cognitive impairment. Until now, it was thought that this was due to the physical presence of the tumor pressing on neural tissue. But this "mass effect" hypothesis ...
Aug 30, 2023
0
56
An estimated one in four older Americans with dementia or mild cognitive impairment lives alone and is at risk of practices like unsafe driving, wandering outside the home, mixing up medications and failing to attend medical ...
Aug 18, 2023
0
62
A new study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants aged 60 and older to elaborate risk across sex and across the intersection of sex and race. The study, the largest ...
Jul 21, 2023
1
16
The findings of the first randomized controlled trial (RCT) of its kind involving nearly 1,000 older adults from multiple locations across the U.S., published in The Lancet, add to the growing evidence that addressing hearing ...
Jul 18, 2023
0
64
With yet a third new Alzheimer's drug expected to be approved by the Food and Drug Administration (FDA), the field is beginning to show progress in the fight to slow the disease.
Jul 17, 2023
0
40
Gulf War Illness (GWI) is a chronic multisymptom health condition affecting one-third of all veterans who served in the 1991 Gulf War, most of whom remain afflicted more than 30 years later. Common symptoms include fatigue, ...
Jul 13, 2023
0
150